IP Library Granted Patent US 7,974,787
Granted Patent B2
US 7,974,787 · App. 12/154,275 · Granted Jul 5, 2011

Combination treatment alteration methods and systems

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,974,787
App. No.
12/154,275
Granted
Jul 5, 2011
Kind
B2
Abstract

Methods, computer program products, and systems are described that include detecting at least one indication of bioactive agent use by an individual and/or altering an artificial sensory experience to modify at least one effect of the bioactive agent.

Claims (84)

1. A computer-implemented method comprising:

detecting at least one indication of bioactive agent use by an individual; and

altering an artificial sensory experience to modify at least one effect of the bioactive agent.

2. A system comprising:

means for detecting at least one indication of bioactive agent use by an individual; and

means for altering an artificial sensory experience to modify at least one effect of the bioactive agent.

3. The system of claim 2 wherein the means for detecting at least one indication of bioactive agent use by an individual comprises:

means for analyzing at least one of sweat, blood, breath, heart rate, brain activity, respiration, or voice quality to detect the at least one indication of bioactive agent use by the individual.

4. The system of claim 3 wherein the means for analyzing at least one of sweat, blood, breath, heart rate, brain activity, respiration, or voice quality to detect the at least one indication of bioactive agent use by the individual comprises:

means for analyzing brain activity using at least one of near infra-red imaging, EEG, magnetoencephalography, functional magnetic resonance imaging, or computer-aided tomography.

5. The system of claim 3 wherein the means for analyzing at least one of sweat, blood, breath, heart rate, brain activity, respiration, or voice quality to detect the at least one indication of bioactive agent use by the individual comprises:

means for detecting at least one of an anti-depressant, an anxiolytic medication, a pain medication, a behavior modifying medication, a weight modifying drug, a neurodegenerative disorder medication, or a vascular disease medication as the at least one medication.

6. The system of claim 2 wherein the means for detecting at least one indication of bioactive agent use by an individual comprises:

means for detecting a concentration of the bioactive agent in the individual.

7. The system of claim 2 wherein the means for detecting at least one indication of bioactive agent use by an individual comprises:

means for comparing a measured value of the bioactive agent in the individual to a stored baseline value of the bioactive agent for the individual to identify a differential indicative of bioactive agent use.

8. The system of claim 2 wherein the means for detecting at least one indication of bioactive agent use by an individual comprises:

means for detecting substance use by the individual.

9. The system of claim 8 wherein the means for detecting substance use by the individual comprises:

means for detecting at least one of alcohol use, psychoactive drug use, tranquilizer use, methamphetamine use, or narcotic use.

10. The system of claim 2 wherein the means for detecting at least one indication of bioactive agent use by an individual comprises:

means for detecting a nutraceutical used by the individual.

11. The system of claim 10 wherein the means for detecting a nutraceutical used by the individual comprises:

means for detecting at least one of a memory supplement, an anti-oxidant, a cancer preventative, or a mood-changing agent.

12. The system of claim 2 wherein the means for detecting at least one indication of bioactive agent use by an individual comprises:

means for detecting at least one indication of bioactive agent use by at least one of a computer game participant, a social networking website participant, a virtual world participant, an online student, an online medical information user, or an on-line shopper.

13. The system of claim 2 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for altering access to at least a portion of the artificial sensory experience to modify at least one effect of the bioactive agent.

14. The system of claim 13 wherein the means for altering access to at least a portion of the artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for restricting access to at least a portion of the artificial sensory experience.

15. The system of claim 13 wherein the means for altering access to at least a portion of the artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for granting access to at least a portion of the artificial sensory experience.

16. The system of claim 2 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for altering a visual object in an artificial sensory experience to modify at least one effect of the bioactive agent.

17. The system of claim 16 wherein the means for altering a visual object in an artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for altering a color scheme of an artificial sensory experience to modify at least one effect of the bioactive agent.

18. The system of claim 16 wherein the means for altering a visual object in an artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for altering at least a portion of text of an artificial sensory experience to modify at least one effect of the bioactive agent.

19. The system of claim 2 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for altering a sound in an artificial sensory experience.

20. The system of claim 19 wherein the means for altering a sound in an artificial sensory experience comprises:

means for altering at least a portion of music in the artificial sensory experience.

21. The system of claim 19 wherein the means for altering a sound in an artificial sensory experience comprises:

means for altering at least a portion of ambient noise in the artificial sensory experience.

22. The system of claim 19 wherein the means for altering a sound in an artificial sensory experience comprises:

means for altering at least a portion of voice in the artificial sensory experience.

23. The system of claim 2 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for altering an artificial sensory experience to enhance the efficacy of the bioactive agent.

24. The system of claim 2 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for altering an artificial sensory experience to reduce a side effect of the bioactive agent.

25. The system of claim 2 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for adding at least one of visual or audio content to the artificial sensory experience.

26. The system of claim 2 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for deleting at least one of visual or audio content of the artificial sensory experience.

27. The system of claim 2 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for adding content to the artificial sensory experience and deleting different content of the artificial sensory experience.

28. The system of claim 2 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for altering a sensate experience to modify the at least one effect of the bioactive agent.

29. The system of claim 28 wherein the means for altering a sensate experience to modify the at least one effect of the bioactive agent comprises:

means for altering at least one of an olfactory stimulus, a haptic stimulus, a visual stimulus, an auditory stimulus, or a taste stimulus to modify the at least one effect of the bioactive agent.

30. The system of claim 2 wherein the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprises:

means for altering an artificial sensory experience implemented on a mobile device.

31. The computer-implemented method of claim 2 wherein the means for detecting at least one indication of bioactive agent use by an individual and the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprise:

means for detecting at least one of a pain medication, an antianxiety medication, an anti-addiction medication, an anti-obesity medication, or a mood-altering medication prescribed for the individual and altering an artificial sensory experience to modify at least one effect of the bioactive agent.

32. The system of claim 2 wherein the means for detecting at least one indication of bioactive agent use by an individual and the means for altering an artificial sensory experience to modify at least one effect of the bioactive agent comprise:

means for detecting an anti-depressant medication in the individual and adding at least one cheerful attribute to a virtual world experience to increase an anti-depressive effect of the anti-depressant medication.

33. A system comprising:

circuitry for detecting at least one indication of bioactive agent use by an individual; and

circuitry for altering an artificial sensory experience to modify at least one effect of the bioactive agent.

34. A computer program product comprising:

a signal-bearing medium bearing

one or more instructions for detecting at least one indication of bioactive agent use by an individual; and

one or more instructions for altering an artificial sensory experience to modify at least one effect of the bioactive agent.

35. The computer program product of claim 34 , wherein the signal-bearing medium includes a computer-readable medium.

36. The computer program product of claim 34 , wherein the signal-bearing medium includes a recordable medium.

37. The computer program product of claim 34 , wherein the signal-bearing medium includes a communications medium.

38. A system comprising:

a computing device; and

instructions that when executed on the computing device cause the computing device to

detect at least one indication of bioactive agent use by an individual; and

alter an artificial sensory experience to modify at least one effect of the bioactive agent.

39. The system of claim 38 wherein the computing device comprises:

one or more of a personal digital assistant (PDA), a personal entertainment device, a mobile phone, a laptop computer, a tablet personal computer, a networked computer, a computing system comprised of a cluster of processors, a computing system comprised of a cluster of servers, a workstation computer, and/or a desktop computer.

40. The system of claim 38 , wherein the computing device is operable to accept the at least one attribute of the at least one individual and present the indication of the at least one prescription medication and the at least one artificial sensory experience from at least one memory.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2023
From: PEAR THERAPEUTICS (US), INC.; PEAR THERAPEUTICS, INC.
To: HARVEST BIO LLC
Reel/Frame 064029/0283 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2011
From: SEARETE LLC
To: THE INVENTION SCIENCE FUND I, LLC
Reel/Frame 026835/0938 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2008
From: HYDE, RODERICK A.; ISHIKAWA, MURIEL Y.; LEUTHARDT, ERIC C.; LEVIEN, ROYCE A.; LORD, ROBERT W.; MALAMUD, MARK A.; SWEENEY, ELIZABETH A.; WOOD, JR., LOWELL L.; WOOD, VICTORIA Y.H.
To: SEARETE LLC
Reel/Frame 021400/0008 →
Continuity (3)
Continuation In Part 12150122 · Apr 24, 2008
Continuation In Part 12152266 · May 13, 2008
Related Publication 20090270692A1 · Oct 29, 2009